US Stock MarketDetailed Quotes

NMTRQ 9 METERS BIOPHARMA INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Nov 4 16:00 ET
14.46Market Cap0.00P/E (TTM)

9 METERS BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
0
0
Operating expense
12.52%12.79M
32.72%42.02M
12.30%10.74M
3.32%8.72M
35.56%11.2M
110.48%11.36M
47.57%31.66M
100.29%9.56M
33.81%8.44M
35.28%8.26M
Selling and administrative expenses
-0.25%2.99M
13.93%11.01M
-22.64%1.95M
1.30%2.42M
43.03%3.65M
35.63%3M
-8.15%9.66M
93.58%2.52M
26.23%2.39M
-54.92%2.55M
-General and administrative expense
-0.25%2.99M
13.93%11.01M
-22.64%1.95M
1.30%2.42M
43.03%3.65M
35.63%3M
-8.15%9.66M
93.58%2.52M
26.23%2.39M
-54.92%2.55M
Research and development costs
17.10%9.8M
40.98%31.01M
24.78%8.79M
4.12%6.3M
32.23%7.55M
162.31%8.37M
101.18%22M
102.80%7.05M
37.06%6.05M
1,183.06%5.71M
Operating profit
-12.52%-12.79M
-32.72%-42.02M
-12.30%-10.74M
-3.32%-8.72M
-35.56%-11.2M
-110.48%-11.36M
-47.57%-31.66M
-100.29%-9.56M
-33.81%-8.44M
-35.28%-8.26M
Net non-operating interest income expense
-4,800.50%-588.03K
-8,747.93%-2.17M
-15,825.50%-1.53M
-124,801.57%-715.69K
1,120.69%65.32K
132.10%12.51K
99.39%-24.48K
102.85%9.72K
99.97%-573
100.53%5.35K
Non-operating interest income
1,185.99%164.79K
2,107.37%501.23K
2,898.97%291.44K
9,324.12%131.66K
904.14%65.32K
151.90%12.81K
19.56%22.71K
271.45%9.72K
-57.60%1.4K
-23.92%6.51K
Non-operating interest expense
247,538.16%752.82K
5,552.47%2.67M
--1.82M
42,912.23%847.34K
--0
-99.31%304
-98.83%47.19K
--0
-99.91%1.97K
-99.89%1.15K
Other net income (expense)
-492.93K
108.18%416.7K
339.7K
101.51%77K
85.85%-5.1M
0
-6,034.60%-5.1M
Gain on sale of security
---78.64K
6,142.86%437K
--360K
--77K
----
----
100.19%7K
--0
----
----
Special income (charges)
---414.29K
99.60%-20.3K
---20.3K
--0
----
--0
84.18%-5.1M
--0
---5.1M
----
-Less:Other special charges
--414.29K
-99.60%20.3K
----
----
----
----
-84.18%5.1M
--0
--5.1M
----
Income before tax
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Net income continuous Operations
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Minority interest income
Net income attributable to the parent company
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Basic earnings per share
-15.91%-1.02
-11.55%-3.38
-22.67%-0.92
32.08%-0.72
-33.33%-0.8
-46.67%-0.88
73.88%-3.03
-54.63%-0.75
11.67%-1.06
94.74%-0.6
Diluted earnings per share
-15.91%-1.02
-11.55%-3.38
-22.67%-0.92
32.08%-0.72
-33.33%-0.8
-46.67%-0.88
73.88%-3.03
-54.63%-0.75
11.67%-1.06
94.74%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit 00
Operating expense 12.52%12.79M32.72%42.02M12.30%10.74M3.32%8.72M35.56%11.2M110.48%11.36M47.57%31.66M100.29%9.56M33.81%8.44M35.28%8.26M
Selling and administrative expenses -0.25%2.99M13.93%11.01M-22.64%1.95M1.30%2.42M43.03%3.65M35.63%3M-8.15%9.66M93.58%2.52M26.23%2.39M-54.92%2.55M
-General and administrative expense -0.25%2.99M13.93%11.01M-22.64%1.95M1.30%2.42M43.03%3.65M35.63%3M-8.15%9.66M93.58%2.52M26.23%2.39M-54.92%2.55M
Research and development costs 17.10%9.8M40.98%31.01M24.78%8.79M4.12%6.3M32.23%7.55M162.31%8.37M101.18%22M102.80%7.05M37.06%6.05M1,183.06%5.71M
Operating profit -12.52%-12.79M-32.72%-42.02M-12.30%-10.74M-3.32%-8.72M-35.56%-11.2M-110.48%-11.36M-47.57%-31.66M-100.29%-9.56M-33.81%-8.44M-35.28%-8.26M
Net non-operating interest income expense -4,800.50%-588.03K-8,747.93%-2.17M-15,825.50%-1.53M-124,801.57%-715.69K1,120.69%65.32K132.10%12.51K99.39%-24.48K102.85%9.72K99.97%-573100.53%5.35K
Non-operating interest income 1,185.99%164.79K2,107.37%501.23K2,898.97%291.44K9,324.12%131.66K904.14%65.32K151.90%12.81K19.56%22.71K271.45%9.72K-57.60%1.4K-23.92%6.51K
Non-operating interest expense 247,538.16%752.82K5,552.47%2.67M--1.82M42,912.23%847.34K--0-99.31%304-98.83%47.19K--0-99.91%1.97K-99.89%1.15K
Other net income (expense) -492.93K108.18%416.7K339.7K101.51%77K85.85%-5.1M0-6,034.60%-5.1M
Gain on sale of security ---78.64K6,142.86%437K--360K--77K--------100.19%7K--0--------
Special income (charges) ---414.29K99.60%-20.3K---20.3K--0------084.18%-5.1M--0---5.1M----
-Less:Other special charges --414.29K-99.60%20.3K-----------------84.18%5.1M--0--5.1M----
Income before tax -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Income tax 0000000000
Net income -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Net income continuous Operations -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Minority interest income
Net income attributable to the parent company -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Basic earnings per share -15.91%-1.02-11.55%-3.38-22.67%-0.9232.08%-0.72-33.33%-0.8-46.67%-0.8873.88%-3.03-54.63%-0.7511.67%-1.0694.74%-0.6
Diluted earnings per share -15.91%-1.02-11.55%-3.38-22.67%-0.9232.08%-0.72-33.33%-0.8-46.67%-0.8873.88%-3.03-54.63%-0.7511.67%-1.0694.74%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data